August 7, 2009in Commercialization, Innovation, IP, Pharmaceutical Drugs2by Editor347 Federal Court Ruling Upholds Data Protection Period for Research-Based, Innovative Drug Companies The period of data protection allocated to research-based, innovative drug companies is a hotly debated topic in the pharmaceutical industry and beyond. This period of protection allows research-based, brand name drug…
